SPOTLIGHT -
The immune-brain loop: a world where more and more clinicians boldly go-and thrive-among new discoveries.
The Week in Review: September 25-29
Blue Light Blockers: A Behavior Therapy for Mania
FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD
Blue Light, Depression, and Bipolar Disorder
Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations
Updates in Pediatric Boarding: A Review of National Pediatric Boarding Consensus Panel Recommendations